Perspectives on the Future Development of Mobile Applications for Dermatology Clinical Research Edward HadelerJulie HongWilson Liao Commentary Open access 07 September 2021 Pages: 1451 - 1456
Dermatologic Care of Hair in Transgender Patients: A Systematic Review of Literature Catherine C. MotoskoAntonella Tosti Review Open access 07 July 2021 Pages: 1457 - 1468
Review of the Latest Methods of Epidermolysis Bullosa and Other Chronic Wounds Treatment Including BIOOPA Dressing Magdalena NitaJacek PliszczyńskiPiotr Fiedor Review Open access 15 July 2021 Pages: 1469 - 1480
Current Trends of Immunotherapy in the Treatment of Cutaneous Melanoma: A Review Piyu Parth Naik Review Open access 02 August 2021 Pages: 1481 - 1496
Psoriasis and Cardiometabolic Comorbidities: An Evaluation of the Impact of Systemic Treatments in Randomized Clinical Trials Megan MoscaJulie HongTina Bhutani Review Open access 10 September 2021 Pages: 1497 - 1520
The Unmet Needs in Atopic Dermatitis Control in Latin America: A Multidisciplinary Expert Perspective Jorge SanchezIvan Cherrez-OjedaBenjamin Hidalgo Review Open access 27 August 2021 Pages: 1521 - 1540
Mast Cell Stabilizers in the Treatment of Rosacea: A Review of Existing and Emerging Therapies Mark C. MarchittoAnna L. Chien Review Open access 02 September 2021 Pages: 1541 - 1549
Psychometric Validation of the Psoriasis Symptoms and Impacts Measure (P-SIM), a Novel Patient-Reported Outcome Instrument for Patients with Plaque Psoriasis, Using Data from the BE VIVID and BE READY Phase 3 Trials Richard B. WarrenAlice B. GottliebValerie Ciaravino Original Research Open access 14 July 2021 Pages: 1551 - 1569
Inadequate Disease Control, Treatment Dissatisfaction, and Quality-of-Life Impairments Among US Patients Receiving Topical Therapy for Atopic Dermatitis Peter AndersonJenny AustinVijay N. Joish Original Research Open access 15 July 2021 Pages: 1571 - 1585
Efficacy and Safety of Platelet-Rich Plasma in Melasma: A Systematic Review and Meta-Analysis Lingyun ZhaoMeng HuLi Li Original Research Open access 16 July 2021 Pages: 1587 - 1597
Baricitinib Rapidly Improves Skin Pain Resulting in Improved Quality of Life for Patients with Atopic Dermatitis: Analyses from BREEZE-AD1, 2, and 7 Jacob P. ThyssenTimo BuhlSonja Ständer Original Research Open access 18 July 2021 Pages: 1599 - 1611
Secukinumab Demonstrated High Effectiveness in Vietnamese Patients with Moderate-To-Severe Plaque Psoriasis in a Real-World Clinical Setting: 16 Week Results from an Observational Study Hao T. NguyenNhi T. U. PhamThao T. P. Vu Original Research Open access 18 July 2021 Pages: 1613 - 1621
COVE-1: A Phase 2, Open-Label Study to Evaluate Efficacy and Safety and the Optimal Regimen of VP-102, a Proprietary Drug–Device Product Containing Topical Cantharidin (0.7% w/v) Under Occlusion for the Treatment of Common Warts Scott GuenthnerWendy McFaldaMelissa Olivadoti Original Research Open access 21 July 2021 Pages: 1623 - 1634
An Economic Analysis of the Impact of Homecare Drug Administration for Biologic Interventions Available for Plaque Psoriasis in the UK William GreenRichard StorkAyeda Nadeem Original Research Open access 23 July 2021 Pages: 1635 - 1642
Dupilumab Demonstrates Rapid and Consistent Improvement in Extent and Signs of Atopic Dermatitis Across All Anatomical Regions in Pediatric Patients 6 Years of Age and Older Eric L. SimpsonAmy S. PallerAshish Bansal Original Research Open access 24 August 2021 Pages: 1643 - 1656
Long-Term Proactive Treatment of Plaque Psoriasis with Calcipotriene/Betamethasone Dipropionate Foam Prolongs Remission and Reduces Relapses Irrespective of Patient Baseline Characteristics Mark G. LebwohlKim A. PappRichard B. Warren Original Research Open access 02 August 2021 Pages: 1657 - 1665
Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis Bob GengAdelaide A. HebertMark G. Lebwohl Original Research Open access 11 August 2021 Pages: 1667 - 1678
Correction to: Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis Bob GengAdelaide A. HebertMark G. Lebwohl Correction Open access 22 September 2021 Pages: 1679 - 1679
Effect of Vitamin-Containing Amino Acid Supplements on Menopausal Symptoms and Age-Related Skin Changes: A Randomised, Double-Blind, Placebo-Controlled Study Rie YamashitaMasahiko OoeHiroshi Matsunaka Original Research Open access 22 August 2021 Pages: 1681 - 1692
Patient Journey in Atopic Dermatitis: The Real-World Scenario Jose Manuel CarrascosaPablo de la CuevaFrancisco José Rebollo Original Research Open access 23 August 2021 Pages: 1693 - 1705
The Use of Real-World Data to Evaluate the Association Between Atopic Dermatitis and Cardiovascular Disease: A Retrospective Claims Analysis Jashin J. WuCaroline AmandLaurent Eckert Original Research Open access 27 August 2021 Pages: 1707 - 1715
Efficacy and Safety of Novel Formulation of Clobetasol Propionate 0.025% Cream in Indian Moderate-to-Severe Psoriasis Patients: Phase-2a, Randomized 3-Arm Study Srinivas SidgiddiSyed Mujtaba Hussain NaqviAmey Mane Original Research Open access 28 August 2021 Pages: 1717 - 1732
Real-World Satisfaction with Secukinumab in Clearing the Skin of Patients with Plaque Psoriasis through 24 Months of Follow-Up: Results from US Dermatology Electronic Medical Records April W. ArmstrongDhaval PatilPaul S. Yamauchi Original Research Open access 28 August 2021 Pages: 1733 - 1749
A Randomized Double-Blind Parallel-Group Study to Evaluate the Long-Term Effects of a Medical Device Containing 0.3% Octatrienoic Acid in the Treatment of Grade III Actinic Keratosis Graziella BabinoStefano CaccavaleGiuseppe Argenziano Original Research Open access 02 September 2021 Pages: 1751 - 1762
Selectivity Profile of the Tyrosine Kinase 2 Inhibitor Deucravacitinib Compared with Janus Kinase 1/2/3 Inhibitors Anjaneya ChimalakondaJames BurkeJohn Throup Original Research Open access 30 August 2021 Pages: 1763 - 1776
Health-Related Quality of Life of Patients with Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma Treated with Pembrolizumab in KEYNOTE-629 Brett G. M. HughesRene Gonzalez MendozaJean-Jacques Grob Original Research Open access 23 September 2021 Pages: 1777 - 1790
Beyond-Mild Psoriasis: A Consensus Statement on Calcipotriol and Betamethasone Dipropionate Foam for the Topical Treatment of Adult Patients Roland AschoffAnthony BewleyMichael Sticherling Original Research Open access 12 September 2021 Pages: 1791 - 1804
Practical Management of Patients with Atopic Dermatitis on Dupilumab Kim A. PappChih-ho HongNeil H. Shear Original Research Open access 11 September 2021 Pages: 1805 - 1828
Recognition and Management of Hereditary Angioedema: Best Practices for Dermatologists Michael E. Manning Brief Report Open access 30 August 2021 Pages: 1829 - 1838
Key Clinical Adverse Events in Patients with Advanced Basal Cell Carcinoma Treated with Sonidegib or Vismodegib: A Post Hoc Analysis Ralf GutzmerCarmen LoquaiMeenal Kheterpal Brief Report Open access 06 September 2021 Pages: 1839 - 1849
A Survey of Community Dermatologists Reveals the Unnecessary Impact of Trial-and-Error Behavior on the Psoriasis Biologic Treatment Paradigm Bruce StroberDavid PariserAlan Menter Practical Approach Open access 18 July 2021 Pages: 1851 - 1860
Itraconazole Oral Solution for a Case of Infantile Hemangioma: Monitoring the Efficacy by Dermoscopy and MRI Ying HuangXin RanYuping Ran Case Report Open access 24 July 2021 Pages: 1861 - 1866
